Thermo Fisher Scientific (TMO)'s Chief Financial Officer To Retire In Early 2016

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Peter M. Wilver, senior vice president and chief financial officer, has decided to retire, effective March 31, 2016. The company's board of directors has elected Stephen Williamson, currently vice president of financial operations, as his successor, effective August 1, 2015. Williamson will report to Marc N. Casper, president and chief executive officer of Thermo Fisher.

Suggested Articles

The FDA slapped a partial clinical hold on the phase 2/3 study of Inovio’s COVID-19 vaccine because it has “additional questions” about the trial.

Preclinical inflammatory disease biotech Ilias Biologics has grabbed a $20.6 million funding round as it eyes a 2021 human test of its leading asset.

Aligos Therapeutics is shooting for a $100 million IPO to help drive its early work on a functional cure for chronic hepatitis B as well as COVID-19.